{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:27:50Z","timestamp":1787776070831,"version":"build-2784847793"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiometabolic multimorbidity (CMM) is increasingly common in older adults and is closely linked to insulin resistance (IR). However, whether IR surrogates perform similarly across heterogeneous obesity phenotypes remains unclear. Using the English Longitudinal Study of Ageing (ELSA), we examined the phenotype-specific associations of the triglyceride\u2013glucose (TyG) index and the estimated glucose disposal rate (eGDR) with incident CMM and compared their predictive utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 4,198 participants from the ELSA in our analysis. Cox proportional hazards models and restricted cubic splines were used to evaluate the association between IR markers (the TyG index and eGDR) and the risk of CMM, as well as to assess potential nonlinearity. We then quantified the IR\u2013related disease burden across obesity phenotypes using the population attributable fraction (PAF) and compared the predictive importance of variables across obesity subgroups using Shapley additive explanations (SHAP) values derived from machine learning models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a median follow-up of 6.8\u202fyears, there were 547 incident CMM events. The association between IR and CMM was strongest in the predominantly isolated central obesity group, surpassing those observed in the no obesity-risk and dual obesity-risk groups. In this subgroup, each 1-standard deviation (SD) increase in the TyG index was linked to a 60.8% higher risk of incident CMM, whereas each 1-SD increase in eGDR was linked to a 60.1% lower risk. Restricted cubic spline analyses revealed monotonic, linear associations for both TyG and eGDR across all three obesity phenotype groups. PAF analyses further showed that the predominantly isolated central obesity group had the highest attributable burden for both TyG and eGDR (37 and 65%, respectively). In internal validation, the machine learning models demonstrated promising discriminative ability, with areas under the curve of 0.827, 0.945, and 0.881. SHAP analyses identified eGDR and TyG as the leading contributors to model predictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IR surrogates were associated with incident CMM and showed potential utility for CMM risk prediction, with the strongest gradients and greatest population impact observed in the predominantly isolated central obesity phenotype. eGDR may be particularly useful for phenotype-tailored CMM risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1805727","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:07Z","timestamp":1783575247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The associations of the triglyceride\u2013glucose index and estimated glucose disposal rate with incident cardiometabolic multimorbidity vary across obesity phenotypes: a longitudinal cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Chenyang","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Xiangya Hospital of Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupu","family":"Shao","sequence":"additional","affiliation":[{"name":"Experimental Center, Department of Basic Medicine, Henan Medical College","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Luo","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhengzhou Central Hospital Affiliated to Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/S0140-6736(09)61863-8","article-title":"Multimorbidity: another key issue for cardiovascular medicine","volume":"374","author":"Glynn","year":"2009","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1001\/jama.2012.5265","article-title":"Designing health care for the most common chronic condition--multimorbidity","volume":"307","author":"Tinetti","year":"2012","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/jama.298.10.1160-b","article-title":"Patterns of prevalent major chronic disease among older adults in the United States","volume":"298","author":"Weiss","year":"2007","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19084726","article-title":"Trends in the prevalence of cardiometabolic multimorbidity in the United States, 1999-2018","volume":"19","author":"Cheng","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.10410","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/fampra\/cmab129","article-title":"Cardiometabolic multimorbidity and activity limitation: a cross-sectional study of adults using the Canadian longitudinal study on aging data","volume":"39","author":"Fishbook","year":"2022","journal-title":"Fam Pract"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-025-02576-0","article-title":"Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"155919","DOI":"10.1016\/j.metabol.2024.155919","article-title":"Obesity and dyslipidemia in early life: impact on cardiometabolic risk","volume":"156","author":"Zeljkovic","year":"2024","journal-title":"Metabolism"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1212\/WNL.59.6.809","article-title":"Insulin resistance and risk for stroke","volume":"59","author":"Kernan","year":"2002","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1598659","DOI":"10.3389\/fnut.2025.1598659","article-title":"Exploring the synergistic effects of life\u2019s essential 8, insulin resistance, and CRP on cardiometabolic multimorbidity risk","volume":"12","author":"Liu","year":"2025","journal-title":"Front Nutr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3803\/EnM.2017.32.3.375","article-title":"A novel index using soluble CD36 is associated with the prevalence of type 2 diabetes mellitus: comparison study with triglyceride-glucose index","volume":"32","author":"Kim","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","article-title":"TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study","volume":"93","author":"Vasques","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12933-025-02963-7","article-title":"Associations between triglyceride-glucose-related indices and all-cause and cardiovascular mortality among individuals with atrial fibrillation and metabolic syndrome: a cohort study of the UK biobank","volume":"24","author":"Ding","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-023-01925-1","article-title":"Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients","volume":"22","author":"Lu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/dom.13110","article-title":"Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes","volume":"20","author":"Nystr\u00f6m","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/meta.2002.30021","article-title":"Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes","volume":"51","author":"Olson","year":"2002","journal-title":"Metabolism"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12933-024-02256-5","article-title":"Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e3764","DOI":"10.1002\/dmrr.3764","article-title":"Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: insights from the China health and retirement longitudinal study","volume":"40","author":"Xiao","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"111894","DOI":"10.1016\/j.diabres.2024.111894","article-title":"Estimated glucose disposal rate, high sensitivity C-reactive protein and cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide prospective cohort study","volume":"217","author":"Xu","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-03064-1","article-title":"Predictive value of an integrated insulin resistance and lipometabolic score for cardiometabolic multimorbidity in older adults: a UK cohort study","volume":"25","author":"Li","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e2537619","DOI":"10.1001\/jamanetworkopen.2025.37619","article-title":"Implications of a new obesity definition among the all of us cohort","volume":"8","author":"Fourman","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12933-025-02967-3","article-title":"Elevated triglyceride-glucose index and its combination with anthropometric indices as indicators of the risk of new-onset transient ischemic attack: a prospective cohort study","volume":"24","author":"Xiao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-022-01729-9","article-title":"Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study","volume":"21","author":"Tian","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12933-025-02867-6","article-title":"Development and validation of a machine learning model for predicting vulnerable carotid plaques using routine blood biomarkers and derived indicators: insights into sex-related risk patterns","volume":"24","author":"Y","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/ije\/dys168","article-title":"Cohort profile: the English longitudinal study of ageing","volume":"42","author":"Steptoe","year":"2013","journal-title":"Int J Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e2537942","DOI":"10.1001\/jamanetworkopen.2025.37942","article-title":"Cardiometabolic outcomes among adults with abdominal obesity and normal body mass index","volume":"8","author":"Ahmed","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-025-02591-1","article-title":"The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-025-02729-1","article-title":"Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0-3 and the development of a machine learning prediction model: a nationwide prospective cohort study","volume":"24","author":"Dong","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1161\/CIRCULATIONAHA.122.061183","article-title":"Severe infection and risk of cardiovascular disease: a multicohort study","volume":"147","author":"Sipil\u00e4","year":"2023","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12933-025-02919-x","article-title":"The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study","volume":"24","author":"Lv","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-025-02761-1","article-title":"Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study","volume":"24","author":"Zhou","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","article-title":"Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank","volume":"24","author":"Tian","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12933-025-02939-7","article-title":"Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study","volume":"24","author":"Ruan","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"180324","DOI":"10.1016\/j.scitotenv.2025.180324","article-title":"Long-term exposure to air pollutants with cardiometabolic multimorbidity and mediating role of atherogenic index of plasma and triglyceride-glucose index","volume":"999","author":"Shi","year":"2025","journal-title":"Sci Total Environ"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jdiacomp.2014.03.015","article-title":"BMI and waist circumference are associated with impaired glucose metabolism and type 2 diabetes in normal weight Chinese adults","volume":"28","author":"Li","year":"2014","journal-title":"J Diabetes Complicat"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1111\/dom.70074","article-title":"Beyond BMI: the role of diabetes and central obesity in fracture risk-insights from the UK biobank","volume":"27","author":"Cho","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12933-025-02818-1","article-title":"Interpretable machine learning analysis of immunoinflammatory biomarkers for predicting CHD among NAFLD patients","volume":"24","author":"Dong","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25215218","article-title":"An overview of the role of adipokines in cardiometabolic diseases","volume":"25","author":"Farkhondeh","year":"2020","journal-title":"Molecules"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-025-02667-y","article-title":"Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011-2018","volume":"24","author":"Lai","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4239\/wjd.v7.i19.483","article-title":"Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome","volume":"7","author":"Paniagua","year":"2016","journal-title":"World J Diabetes"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"115337","DOI":"10.1016\/j.bcp.2022.115337","article-title":"Adipose tissue mitochondrial dysfunction and cardiometabolic diseases: on the search for novel molecular targets","volume":"206","author":"AlZaim","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cell.2013.01.041","article-title":"The origins and drivers of insulin resistance","volume":"152","author":"Johnson","year":"2013","journal-title":"Cell"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4274\/balkanmedj.galenos.2018.2018.0789","article-title":"The adipokine profile and the cardiometabolic risk in non-obese young adults","volume":"36","author":"Otelea","year":"2019","journal-title":"Balkan Med J"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"802078","DOI":"10.1155\/2010\/802078","article-title":"The role of adipose tissue and adipokines in obesity-related inflammatory diseases","volume":"2010","author":"Balistreri","year":"2010","journal-title":"Mediat Inflamm"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"139239","DOI":"10.1155\/2013\/139239","article-title":"Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines","volume":"2013","author":"Makki","year":"2013","journal-title":"ISRN Inflamm"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J Cardiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1805727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:08Z","timestamp":1783575248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1805727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":50,"alternative-id":["10.3389\/fnut.2026.1805727"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1805727","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1805727"}}